Alnylam grants Ascletis Chinese rights to ALN-VSP

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) granted Ascletis Pharmaceuticals Co. Ltd. (Chapel Hill, N.C.) exclusive rights in China to develop and commercialize RNAi therapeutic ALN-VSP, which has comp...